Literature DB >> 28677425

IKBKE promotes glioblastoma progression by establishing the regulatory feedback loop of IKBKE/YAP1/miR-Let-7b/i.

Zhimeng Zhang1, Jie Lu1, Gaochao Guo1, Yi Yang1, Shicai Dong1, Yang Liu1, Yang Nan1, Yue Zhong1, Kai Yu1, Qiang Huang1.   

Abstract

Recently, we have demonstrated that IKBKE (inhibitor of nuclear factor kappa-B kinase subunit epsilon) is overexpressed in human glioblastoma and that inhibition of IKBKE remarkably suppresses the proliferative and invasive behaviour of glioblastoma cells. However, the specific pathogenic molecular mechanism remains to be elucidated. In this study, we verified that IKBKE promotes YAP1 expression via posttranslational modification and accelerates YAP1 translocation to the nucleus for the development of glioblastoma. We then determined that YAP1 negatively regulates miR-let-7b/i by overexpressing and silencing YAP1 expression. In addition, miR-let-7b/i feedback decreases the expression of IKBKE and YAP1 and suppresses the transportation of YAP1 located in the nucleus. Therefore, the regulatory feedback circuit of IKBKE↑→YAP1↑→miR-let-7b/i↓→IKBKE↑ dictates glioblastoma progression. Thus, we propose that blocking the circuit may be a new therapeutic strategy for the treatment of glioblastoma.

Entities:  

Keywords:  Glioblastoma; IKBKE; YAP1; feedback circuit; miR-let-7b/i

Mesh:

Substances:

Year:  2017        PMID: 28677425     DOI: 10.1177/1010428317705575

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  5 in total

1.  Short non-coding RNA sequencing of glioblastoma extracellular vesicles.

Authors:  Tristan de Mooij; Timothy E Peterson; Jared Evans; Brandon McCutcheon; Ian F Parney
Journal:  J Neurooncol       Date:  2020-01-07       Impact factor: 4.130

2.  MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.

Authors:  Tie Liu; Anqi Li; Yulun Xu; Yu Xin
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452

Review 3.  Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.

Authors:  Xiaomin Liu; Yang Shao; Jinbao Zhou; Guangren Qian; Zhongliang Ma
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

Review 4.  Advances in IKBKE as a potential target for cancer therapy.

Authors:  Min Yin; Xin Wang; Jie Lu
Journal:  Cancer Med       Date:  2019-11-15       Impact factor: 4.452

Review 5.  Advancing towards Effective Glioma Therapy: MicroRNA Derived from Umbilical Cord Mesenchymal Stem Cells' Extracellular Vesicles.

Authors:  Eko Ngadiono; Novi Silvia Hardiany
Journal:  Malays J Med Sci       Date:  2019-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.